Sign In
Buy AXSM
$233.49
+11.33 (+5.10%)
At Close: Jun 03, 2026
Axsome (AXSM) Stock Up 17% in Six Months: Here's Why
01:46pm, Monday, 20'th Mar 2023
Axsome's (AXSM) shares have surged 17.2% in the past six months, owing to the launch of its first product, Auvelity, in October last year. Also, the addition of Sunosi boosts its top line.
3 Nasdaq Stocks on Watch This Week
04:45pm, Sunday, 12'th Mar 2023
Market volatility seems to be the central theme for stocks heading into next week. These three Nasdaq-listed stocks may be among the most volatile.
Axsome Therapeutics: SYMPHONY Catalyst Unlocking
02:52pm, Thursday, 09'th Mar 2023
Given that Axsome Therapeutics, Inc. is launching Auvelity with a small in-house team, you can expect a substantial sales increase in the next three years. In a highly favorable deal, Axsome recently
These Are the Top 10 Holdings of David Kim
10:55pm, Monday, 06'th Mar 2023
David Kim is the founder and Chief Investment Officer of Ghost Tree Capital. Before founding Ghost Tree Capital in 2013, Kim worked as the portfolio manager at Diamondback Capital (Nov 2006 – Dec 20
Is Axsome Therapeutics Stock a Buy Now?
06:15am, Monday, 06'th Mar 2023
Axsome Therapeutics' current portfolio could generate over $3 billion in peak annual sales. However, that won't happen for several years.
Axsome (AXSM) Q4 Earnings Miss, Auvelity Records First Sales
03:49pm, Tuesday, 28'th Feb 2023
Axsome Therapeutics (AXSM) incurs wider-than-expected loss in Q4 2022. Revenues beat estimates while shares gain.
Axsome Therapeutics (AXSM) Reports Q4 Loss, Tops Revenue Estimates
09:47am, Monday, 27'th Feb 2023
Axsome (AXSM) delivered earnings and revenue surprises of -8.47% and 13.29%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Axsome: Teva's ANDA Is No Surprise And No Big Deal
11:06am, Monday, 20'th Feb 2023
Teva filed an ANDA challenge against Auvelity four months after approval. The filing defines, for me, the hurdles generics will face in challenging Axsome's huge patent estate.
Axsome Therapeutics (AXSM) Stock Falls as Teva Pursues Generic Depression Drug
10:34am, Monday, 13'th Feb 2023
Axsome Therapeutics (NASDAQ: AXSM ) stock is taking a beating on Monday as rival Teva Pharmaceutical (NYSE: TEVA ) prepares a generic depression drug. According to a filing with the U.S. Securities an
Axsome's stock falls after disclosing Teva's plans to market generic Auvelity
08:01am, Monday, 13'th Feb 2023
Shares of Axsome Therapeutics Inc. AXSM, -0.27% tumbled about 10.0% in premarket trading on Monday after the company said in a securities filing that Teva Pharmaceutical Industries Ltd. TEVA, +4.48% i
2 Biotech Stocks You Can Buy and Hold for the Next Decade
09:00am, Sunday, 12'th Feb 2023
These companies could grow in prominence in the coming years.
3 Surefire Growth Stocks You Can Buy Right Now
02:31pm, Saturday, 11'th Feb 2023
Maybe there's no such thing as a sure thing. But these stocks could come close.
Axsome Therapeutics to Present at the SVB Securities Global Biopharma Conference
07:00am, Tuesday, 07'th Feb 2023
NEW YORK, Feb. 07, 2023 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system
Axsome Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results on February 27
07:00am, Tuesday, 31'st Jan 2023
Axsome to host conference call and webcast on Monday, Feb. 27, 2023, at 8:00 a.m. ET Axsome to host conference call and webcast on Monday, Feb. 27, 2023, at 8:00 a.m. ET
The Ultimate Growth Stocks to Buy With $300 Right Now
07:25am, Sunday, 29'th Jan 2023
These three companies should deliver inflation-busting long-term growth.
